Global Cell-free Tumor DNA Detection Market Research Report 2024(Status and Outlook)

Global Cell-free Tumor DNA Detection Market Research Report 2024(Status and Outlook)



Report Overview:

Cell-free tumor DNA (circulating tumor DNA, ctDNA) testing, the so-called ""liquid biopsy"". ctDNA refers to the DNA released by tumor cells into the blood circulatory system, which contains information on tumor-derived mutations and gene variations. ctDNA is a tumor marker with broad application prospects, high sensitivity and high specificity, and is suitable for a variety of tumors, providing an opportunity for non-invasive sampling of tumors.

The Global Cell-free Tumor DNA Detection Market Size was estimated at USD 5632.82 million in 2023 and is projected to reach USD 9189.76 million by 2029, exhibiting a CAGR of 8.50% during the forecast period.

This report provides a deep insight into the global Cell-free Tumor DNA Detection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell-free Tumor DNA Detection Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell-free Tumor DNA Detection market in any manner.

Global Cell-free Tumor DNA Detection Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Biocept Inc.

Bio-Rad Laboratories Inc.

Fluxion Biosciences Inc.

F. Hoffmann-La Roche AG

Sysmex Europe SE

Qiagen

NeoGenomics Laboratories Inc.

Menarini Silicon Biosystems

Illumina Inc.

Guardant Health Inc.

Shanghai Biotecan Medical Diagnostics Co.,Ltd.

Market Segmentation (by Type)

Droplet Digital Polymerase Chain Reaction

Tagged-Amplicon Deep Sequencing

Others

Market Segmentation (by Application)

Breast Cancer

Stomach Cancer

Liver Cancer

Other

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Cell-free Tumor DNA Detection Market
  • Overview of the regional outlook of the Cell-free Tumor DNA Detection Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell-free Tumor DNA Detection Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cell-free Tumor DNA Detection
1.2 Key Market Segments
1.2.1 Cell-free Tumor DNA Detection Segment by Type
1.2.2 Cell-free Tumor DNA Detection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Cell-free Tumor DNA Detection Market Overview
2.1 Global Market Overview
2.1.1 Global Cell-free Tumor DNA Detection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cell-free Tumor DNA Detection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Cell-free Tumor DNA Detection Market Competitive Landscape
3.1 Global Cell-free Tumor DNA Detection Sales by Manufacturers (2019-2024)
3.2 Global Cell-free Tumor DNA Detection Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell-free Tumor DNA Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell-free Tumor DNA Detection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell-free Tumor DNA Detection Sales Sites, Area Served, Product Type
3.6 Cell-free Tumor DNA Detection Market Competitive Situation and Trends
3.6.1 Cell-free Tumor DNA Detection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell-free Tumor DNA Detection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Cell-free Tumor DNA Detection Industry Chain Analysis
4.1 Cell-free Tumor DNA Detection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cell-free Tumor DNA Detection Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Cell-free Tumor DNA Detection Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell-free Tumor DNA Detection Sales Market Share by Type (2019-2024)
6.3 Global Cell-free Tumor DNA Detection Market Size Market Share by Type (2019-2024)
6.4 Global Cell-free Tumor DNA Detection Price by Type (2019-2024)
7 Cell-free Tumor DNA Detection Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell-free Tumor DNA Detection Market Sales by Application (2019-2024)
7.3 Global Cell-free Tumor DNA Detection Market Size (M USD) by Application (2019-2024)
7.4 Global Cell-free Tumor DNA Detection Sales Growth Rate by Application (2019-2024)
8 Cell-free Tumor DNA Detection Market Segmentation by Region
8.1 Global Cell-free Tumor DNA Detection Sales by Region
8.1.1 Global Cell-free Tumor DNA Detection Sales by Region
8.1.2 Global Cell-free Tumor DNA Detection Sales Market Share by Region
8.2 North America
8.2.1 North America Cell-free Tumor DNA Detection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell-free Tumor DNA Detection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell-free Tumor DNA Detection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell-free Tumor DNA Detection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell-free Tumor DNA Detection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Biocept Inc.
9.1.1 Biocept Inc. Cell-free Tumor DNA Detection Basic Information
9.1.2 Biocept Inc. Cell-free Tumor DNA Detection Product Overview
9.1.3 Biocept Inc. Cell-free Tumor DNA Detection Product Market Performance
9.1.4 Biocept Inc. Business Overview
9.1.5 Biocept Inc. Cell-free Tumor DNA Detection SWOT Analysis
9.1.6 Biocept Inc. Recent Developments
9.2 Bio-Rad Laboratories Inc.
9.2.1 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Basic Information
9.2.2 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Overview
9.2.3 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection Product Market Performance
9.2.4 Bio-Rad Laboratories Inc. Business Overview
9.2.5 Bio-Rad Laboratories Inc. Cell-free Tumor DNA Detection SWOT Analysis
9.2.6 Bio-Rad Laboratories Inc. Recent Developments
9.3 Fluxion Biosciences Inc.
9.3.1 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Basic Information
9.3.2 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Overview
9.3.3 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection Product Market Performance
9.3.4 Fluxion Biosciences Inc. Cell-free Tumor DNA Detection SWOT Analysis
9.3.5 Fluxion Biosciences Inc. Business Overview
9.3.6 Fluxion Biosciences Inc. Recent Developments
9.4 F. Hoffmann-La Roche AG
9.4.1 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Basic Information
9.4.2 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Overview
9.4.3 F. Hoffmann-La Roche AG Cell-free Tumor DNA Detection Product Market Performance
9.4.4 F. Hoffmann-La Roche AG Business Overview
9.4.5 F. Hoffmann-La Roche AG Recent Developments
9.5 Sysmex Europe SE
9.5.1 Sysmex Europe SE Cell-free Tumor DNA Detection Basic Information
9.5.2 Sysmex Europe SE Cell-free Tumor DNA Detection Product Overview
9.5.3 Sysmex Europe SE Cell-free Tumor DNA Detection Product Market Performance
9.5.4 Sysmex Europe SE Business Overview
9.5.5 Sysmex Europe SE Recent Developments
9.6 Qiagen
9.6.1 Qiagen Cell-free Tumor DNA Detection Basic Information
9.6.2 Qiagen Cell-free Tumor DNA Detection Product Overview
9.6.3 Qiagen Cell-free Tumor DNA Detection Product Market Performance
9.6.4 Qiagen Business Overview
9.6.5 Qiagen Recent Developments
9.7 NeoGenomics Laboratories Inc.
9.7.1 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Basic Information
9.7.2 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Overview
9.7.3 NeoGenomics Laboratories Inc. Cell-free Tumor DNA Detection Product Market Performance
9.7.4 NeoGenomics Laboratories Inc. Business Overview
9.7.5 NeoGenomics Laboratories Inc. Recent Developments
9.8 Menarini Silicon Biosystems
9.8.1 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Basic Information
9.8.2 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Overview
9.8.3 Menarini Silicon Biosystems Cell-free Tumor DNA Detection Product Market Performance
9.8.4 Menarini Silicon Biosystems Business Overview
9.8.5 Menarini Silicon Biosystems Recent Developments
9.9 Illumina Inc.
9.9.1 Illumina Inc. Cell-free Tumor DNA Detection Basic Information
9.9.2 Illumina Inc. Cell-free Tumor DNA Detection Product Overview
9.9.3 Illumina Inc. Cell-free Tumor DNA Detection Product Market Performance
9.9.4 Illumina Inc. Business Overview
9.9.5 Illumina Inc. Recent Developments
9.10 Guardant Health Inc.
9.10.1 Guardant Health Inc. Cell-free Tumor DNA Detection Basic Information
9.10.2 Guardant Health Inc. Cell-free Tumor DNA Detection Product Overview
9.10.3 Guardant Health Inc. Cell-free Tumor DNA Detection Product Market Performance
9.10.4 Guardant Health Inc. Business Overview
9.10.5 Guardant Health Inc. Recent Developments
9.11 Shanghai Biotecan Medical Diagnostics Co.,Ltd.
9.11.1 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Basic Information
9.11.2 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Overview
9.11.3 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Cell-free Tumor DNA Detection Product Market Performance
9.11.4 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Business Overview
9.11.5 Shanghai Biotecan Medical Diagnostics Co.,Ltd. Recent Developments
10 Cell-free Tumor DNA Detection Market Forecast by Region
10.1 Global Cell-free Tumor DNA Detection Market Size Forecast
10.2 Global Cell-free Tumor DNA Detection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell-free Tumor DNA Detection Market Size Forecast by Country
10.2.3 Asia Pacific Cell-free Tumor DNA Detection Market Size Forecast by Region
10.2.4 South America Cell-free Tumor DNA Detection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell-free Tumor DNA Detection by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Cell-free Tumor DNA Detection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cell-free Tumor DNA Detection by Type (2025-2030)
11.1.2 Global Cell-free Tumor DNA Detection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cell-free Tumor DNA Detection by Type (2025-2030)
11.2 Global Cell-free Tumor DNA Detection Market Forecast by Application (2025-2030)
11.2.1 Global Cell-free Tumor DNA Detection Sales (K Units) Forecast by Application
11.2.2 Global Cell-free Tumor DNA Detection Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings